Differential expression of hMLH1 in sporadic human colorectal cancer tumors and distant metastases

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Differential expression of hMLH1 in sporadic human colorectal cancer tumors and distant metastases. / Larsen, Nicolai Balle; Heiberg Engel, Peter Johan; Rasmussen, Merete; Rasmussen, Lene Juel.

In: Acta Pathologica Microbiologica et Immunologica Scandinavica, Vol. 117, No. 11, 2009, p. 839-48.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Larsen, NB, Heiberg Engel, PJ, Rasmussen, M & Rasmussen, LJ 2009, 'Differential expression of hMLH1 in sporadic human colorectal cancer tumors and distant metastases', Acta Pathologica Microbiologica et Immunologica Scandinavica, vol. 117, no. 11, pp. 839-48. https://doi.org/10.1111/j.1600-0463.2009.02543.x

APA

Larsen, N. B., Heiberg Engel, P. J., Rasmussen, M., & Rasmussen, L. J. (2009). Differential expression of hMLH1 in sporadic human colorectal cancer tumors and distant metastases. Acta Pathologica Microbiologica et Immunologica Scandinavica, 117(11), 839-48. https://doi.org/10.1111/j.1600-0463.2009.02543.x

Vancouver

Larsen NB, Heiberg Engel PJ, Rasmussen M, Rasmussen LJ. Differential expression of hMLH1 in sporadic human colorectal cancer tumors and distant metastases. Acta Pathologica Microbiologica et Immunologica Scandinavica. 2009;117(11):839-48. https://doi.org/10.1111/j.1600-0463.2009.02543.x

Author

Larsen, Nicolai Balle ; Heiberg Engel, Peter Johan ; Rasmussen, Merete ; Rasmussen, Lene Juel. / Differential expression of hMLH1 in sporadic human colorectal cancer tumors and distant metastases. In: Acta Pathologica Microbiologica et Immunologica Scandinavica. 2009 ; Vol. 117, No. 11. pp. 839-48.

Bibtex

@article{e3982320a05f11df928f000ea68e967b,
title = "Differential expression of hMLH1 in sporadic human colorectal cancer tumors and distant metastases",
abstract = "Somatic defects in the mismatch repair system constitute an important pathway in colorectal carcinogenesis. We have examined the expression of mismatch repair proteins in sporadic stage IV colorectal tumors and their derived metastases. Sporadic tumors were further examined for differences in expression between the tumor transition zone and the invasive front. Expression of hMSH2, hMLH1, and hPMS2 was screened immunohistochemically in 92 stage IV tumors and derived liver metastases. In cases with loss of mismatch repair protein expression, lymph node metastases were also examined. Clinicopathological parameters and Ki-67 staining indexes were evaluated and compared. Four tumors displayed a complete loss of hMLH1/hPMS2 expression at the transition zone; however, three of these expressed both proteins at the invasive front and in liver and lymph node metastases. A further four were predominantly hMLH1/hPMS2 negative at the transition zone, but with distinct subclones of hMLH1/hPMS2-expressing cells at the transition zone. All of these tumors expressed hMLH1/hPMS2 at the invasive front and in liver metastases, with three also expressing hMLH/hPMS2 in lymph node metastases. No significant difference in the proliferative index was observed for the hMLH1/hPMS2-compromised group. In stage IV tumors re-expression of hMLH1/hPMS2 occurred, leading to different patterns of expression within the primary tumor and between tumor and metastases. This may have functional importance for the chemosensitivity of metastases compared to the primary tumor.",
author = "Larsen, {Nicolai Balle} and {Heiberg Engel}, {Peter Johan} and Merete Rasmussen and Rasmussen, {Lene Juel}",
note = "Keywords: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphatases; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; DNA Repair Enzymes; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kaplan-Meiers Estimate; Liver Neoplasms; Middle Aged; MutS Homolog 2 Protein; Nuclear Proteins; Retrospective Studies",
year = "2009",
doi = "10.1111/j.1600-0463.2009.02543.x",
language = "English",
volume = "117",
pages = "839--48",
journal = "A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica",
issn = "0903-4641",
publisher = "Wiley Online",
number = "11",

}

RIS

TY - JOUR

T1 - Differential expression of hMLH1 in sporadic human colorectal cancer tumors and distant metastases

AU - Larsen, Nicolai Balle

AU - Heiberg Engel, Peter Johan

AU - Rasmussen, Merete

AU - Rasmussen, Lene Juel

N1 - Keywords: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphatases; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; DNA Repair Enzymes; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kaplan-Meiers Estimate; Liver Neoplasms; Middle Aged; MutS Homolog 2 Protein; Nuclear Proteins; Retrospective Studies

PY - 2009

Y1 - 2009

N2 - Somatic defects in the mismatch repair system constitute an important pathway in colorectal carcinogenesis. We have examined the expression of mismatch repair proteins in sporadic stage IV colorectal tumors and their derived metastases. Sporadic tumors were further examined for differences in expression between the tumor transition zone and the invasive front. Expression of hMSH2, hMLH1, and hPMS2 was screened immunohistochemically in 92 stage IV tumors and derived liver metastases. In cases with loss of mismatch repair protein expression, lymph node metastases were also examined. Clinicopathological parameters and Ki-67 staining indexes were evaluated and compared. Four tumors displayed a complete loss of hMLH1/hPMS2 expression at the transition zone; however, three of these expressed both proteins at the invasive front and in liver and lymph node metastases. A further four were predominantly hMLH1/hPMS2 negative at the transition zone, but with distinct subclones of hMLH1/hPMS2-expressing cells at the transition zone. All of these tumors expressed hMLH1/hPMS2 at the invasive front and in liver metastases, with three also expressing hMLH/hPMS2 in lymph node metastases. No significant difference in the proliferative index was observed for the hMLH1/hPMS2-compromised group. In stage IV tumors re-expression of hMLH1/hPMS2 occurred, leading to different patterns of expression within the primary tumor and between tumor and metastases. This may have functional importance for the chemosensitivity of metastases compared to the primary tumor.

AB - Somatic defects in the mismatch repair system constitute an important pathway in colorectal carcinogenesis. We have examined the expression of mismatch repair proteins in sporadic stage IV colorectal tumors and their derived metastases. Sporadic tumors were further examined for differences in expression between the tumor transition zone and the invasive front. Expression of hMSH2, hMLH1, and hPMS2 was screened immunohistochemically in 92 stage IV tumors and derived liver metastases. In cases with loss of mismatch repair protein expression, lymph node metastases were also examined. Clinicopathological parameters and Ki-67 staining indexes were evaluated and compared. Four tumors displayed a complete loss of hMLH1/hPMS2 expression at the transition zone; however, three of these expressed both proteins at the invasive front and in liver and lymph node metastases. A further four were predominantly hMLH1/hPMS2 negative at the transition zone, but with distinct subclones of hMLH1/hPMS2-expressing cells at the transition zone. All of these tumors expressed hMLH1/hPMS2 at the invasive front and in liver metastases, with three also expressing hMLH/hPMS2 in lymph node metastases. No significant difference in the proliferative index was observed for the hMLH1/hPMS2-compromised group. In stage IV tumors re-expression of hMLH1/hPMS2 occurred, leading to different patterns of expression within the primary tumor and between tumor and metastases. This may have functional importance for the chemosensitivity of metastases compared to the primary tumor.

U2 - 10.1111/j.1600-0463.2009.02543.x

DO - 10.1111/j.1600-0463.2009.02543.x

M3 - Journal article

VL - 117

SP - 839

EP - 848

JO - A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica

JF - A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica

SN - 0903-4641

IS - 11

ER -

ID: 21205398